APO Research

APO RESEARCH · REPORT

HEPES

HEPES (N-(2-Hydroxyethyl)piperazine-N'-2-ethanesulfonic Acid)) is a zwitterionic organic chemical buffering agent. HEPES is widely used in cell culture, molecular biology and biochemical researches, largely because it is better at maintaining physiological pH.

Product & engineering

Understand the product.

HEPES (N-(2-Hydroxyethyl)piperazine-N'-2-ethanesulfonic Acid)) is a zwitterionic organic chemical buffering agent. HEPES is widely used in cell culture, molecular biology and biochemical researches, largely because it is better at maintaining physiological pH.

Selected research

Industry Growth & Trends

Global HEPES Industry Growth and Trends Forecast to 2032

Market perspective

HEPES (N-(2-Hydroxyethyl)piperazine-N'-2-ethanesulfonic Acid)) is a zwitterionic organic chemical buffering agent. HEPES is widely used in cell culture, molecular biology and biochemical researches, largely because it is better at maintaining physiological pH.

North America is the largest market with about 56% market share. Europe is follower, accounting for about 27% market share.

The key players are Avantor, Thermo Fisher, Merck, Lonza, Cytiva, Promega Corporation, MP Biomedicals, Spectrum Laboratory, Biological Industries, Cayman Chemical, SERVA Electrophoresis GmbH, Bio-Techne, BioSpectra, Corning, FUJIFILM Irvine Scientific, Inc., Dojindo Laboratories, XZL Bio-Technology, Suzhou Yacoo Science, Haihang Chemical, Yunbang Bio-pharmaceutical etc. Top 3 companies occupied about 29% market share.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global HEPES market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The HEPES market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global HEPES market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to HEPES.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global HEPES market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

HEPES Market by Company

Avantor

Thermo Fisher

Merck

Lonza

Cytiva

Promega Corporation

MP Biomedicals

Spectrum Laboratory

Biological Industries

Cayman Chemical

SERVA Electrophoresis GmbH

Bio-Techne

BioSpectra

Corning

FUJIFILM Irvine Scientific, Inc.

Dojindo Laboratories

XZL Bio-Technology

Suzhou Yacoo Science

Haihang Chemical

Yunbang Bio-pharmaceutical

HEPES Segment by Type

HEPES Powder

HEPES Solution

HEPES Segment by Application

Cell Culture

Protein Extraction

Others

HEPES Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HEPES market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HEPES and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HEPES.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of HEPES manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of HEPES in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of HEPES Powder Table 2. Major Company of HEPES Solution Table 3. Global HEPES Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global HEPES Sales by Type (2021-2026) & (MT) Table 5. Global HEPES Sales Market Share in Volume by Type (2021-2026) Table 6. Global HEPES Sales by Type (2021-2026) & (US$ Million) Table 7. Global HEPES Sales Market Share in Value by Type (2021-2026) Table 8. Global HEPES Price by Type (2021-2026) & (USD/kg) Table 9. Global HEPES Sales by Type (2027-2032) & (MT) Table 10. Global HEPES Sales Market Share in Volume by Type (2027-2032) Table 11. Global HEPES Sales by Type (2027-2032) & (US$ Million) Table 12. Global HEPES Sales Market Share in Value by Type (2027-2032) Table 13. Global HEPES Price by Type (2027-2032) & (USD/kg) Table 14. North America HEPES Sales by Type (2021-2026) & (MT) Table 15. North America HEPES Sales by Type (2021-2026) & (US$ Million) Table 16. Europe HEPES Sales by Type (2021-2026) & (MT) Table 17. Europe HEPES Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific HEPES Sales by Type (2021-2026) & (MT) Table 19. Asia-Pacific HEPES Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America HEPES Sales by Type (2021-2026) & (MT) Table 21. Latin America HEPES Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa HEPES Sales by Type (2021-2026) & (MT) Table 23. Middle East and Africa HEPES Sales by Type (2021-2026) & (US$ Million) Table 24. HEPES Industry Trends Table 25. HEPES Industry Drivers Table 26. HEPES Industry Opportunities and Challenges Table 27. HEPES Industry Restraints Table 28. Global HEPES Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global HEPES Revenue Market Share by Company (2021-2026) Table 30. Global HEPES Sales by Company (2021-2026) & (MT) Table 31. Global HEPES Sales Share by Company (2021-2026) Table 32. Global HEPES Market Price by Company (2021-2026) & (USD/kg) Table 33. Global HEPES Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global HEPES Major Company Production Sites and Headquarters Table 35. Global HEPES Company, Product Type & Application Table 36. Global HEPES Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global HEPES by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global HEPES Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global HEPES Sales by Region (2021-2026) & (MT) Table 41. Global HEPES Sales Market Share in Volume by Region (2021-2026) Table 42. Global HEPES Sales by Region (2021-2026) & (US$ Million) Table 43. Global HEPES Sales Market Share in Value by Region (2021-2026) Table 44. Global HEPES Sales (MT), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 45. Global HEPES Sales by Region (2027-2032) & (MT) Table 46. Global HEPES Sales Market Share in Volume by Region (2027-2032) Table 47. Global HEPES Sales by Region (2027-2032) & (US$ Million) Table 48. Global HEPES Sales Market Share in Value by Region (2027-2032) Table 49. Global HEPES Sales (MT), Value (US$ Million), Price (USD/kg) and Gross Margin (2027-2032) Table 50. Global HEPES Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global HEPES Sales by Application (2021-2026) & (MT) Table 52. Global HEPES Sales Market Share in Volume by Application (2021-2026) Table 53. Global HEPES Sales by Application (2021-2026) & (US$ Million) Table 54. Global HEPES Sales Market Share in Value by Application (2021-2026) Table 55. Global HEPES Price by Application (2021-2026) & (USD/kg) Table 56. Global HEPES Sales by Application (2027-2032) & (MT) Table 57. Global HEPES Sales Market Share in Volume by Application (2027-2032) Table 58. Global HEPES Sales by Application (2027-2032) & (US$ Million) Table 59. Global HEPES Sales Market Share in Value by Application (2027-2032) Table 60. Global HEPES Price by Application (2027-2032) & (USD/kg) Table 61. North America HEPES Sales by Application (2021-2026) & (MT) Table 62. North America HEPES Sales by Application (2021-2026) & (US$ Million) Table 63. Europe HEPES Sales by Application (2021-2026) & (MT) Table 64. Europe HEPES Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific HEPES Sales by Application (2021-2026) & (MT) Table 66. Asia-Pacific HEPES Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America HEPES Sales by Application (2021-2026) & (MT) Table 68. Latin America HEPES Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa HEPES Sales by Application (2021-2026) & (MT) Table 70. Middle East and Africa HEPES Sales by Application (2021-2026) & (US$ Million) Table 71. Avantor Company Information Table 72. Avantor Business Overview Table 73. Avantor HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 74. Avantor HEPES Product Portfolio Table 75. Avantor Recent Development Table 76. Thermo Fisher Company Information Table 77. Thermo Fisher Business Overview Table 78. Thermo Fisher HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 79. Thermo Fisher HEPES Product Portfolio Table 80. Thermo Fisher Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 84. Merck HEPES Product Portfolio Table 85. Merck Recent Development Table 86. Lonza Company Information Table 87. Lonza Business Overview Table 88. Lonza HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 89. Lonza HEPES Product Portfolio Table 90. Lonza Recent Development Table 91. Cytiva Company Information Table 92. Cytiva Business Overview Table 93. Cytiva HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 94. Cytiva HEPES Product Portfolio Table 95. Cytiva Recent Development Table 96. Promega Corporation Company Information Table 97. Promega Corporation Business Overview Table 98. Promega Corporation HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 99. Promega Corporation HEPES Product Portfolio Table 100. Promega Corporation Recent Development Table 101. MP Biomedicals Company Information Table 102. MP Biomedicals Business Overview Table 103. MP Biomedicals HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 104. MP Biomedicals HEPES Product Portfolio Table 105. MP Biomedicals Recent Development Table 106. Spectrum Laboratory Company Information Table 107. Spectrum Laboratory Business Overview Table 108. Spectrum Laboratory HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 109. Spectrum Laboratory HEPES Product Portfolio Table 110. Spectrum Laboratory Recent Development Table 111. Biological Industries Company Information Table 112. Biological Industries Business Overview Table 113. Biological Industries HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 114. Biological Industries HEPES Product Portfolio Table 115. Biological Industries Recent Development Table 116. Cayman Chemical Company Information Table 117. Cayman Chemical Business Overview Table 118. Cayman Chemical HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 119. Cayman Chemical HEPES Product Portfolio Table 120. Cayman Chemical Recent Development Table 121. SERVA Electrophoresis GmbH Company Information Table 122. SERVA Electrophoresis GmbH Business Overview Table 123. SERVA Electrophoresis GmbH HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 124. SERVA Electrophoresis GmbH HEPES Product Portfolio Table 125. SERVA Electrophoresis GmbH Recent Development Table 126. Bio-Techne Company Information Table 127. Bio-Techne Business Overview Table 128. Bio-Techne HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 129. Bio-Techne HEPES Product Portfolio Table 130. Bio-Techne Recent Development Table 131. BioSpectra Company Information Table 132. BioSpectra Business Overview Table 133. BioSpectra HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 134. BioSpectra HEPES Product Portfolio Table 135. BioSpectra Recent Development Table 136. Corning Company Information Table 137. Corning Business Overview Table 138. Corning HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 139. Corning HEPES Product Portfolio Table 140. Corning Recent Development Table 141. FUJIFILM Irvine Scientific, Inc. Company Information Table 142. FUJIFILM Irvine Scientific, Inc. Business Overview Table 143. FUJIFILM Irvine Scientific, Inc. HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 144. FUJIFILM Irvine Scientific, Inc. HEPES Product Portfolio Table 145. FUJIFILM Irvine Scientific, Inc. Recent Development Table 146. Dojindo Laboratories Company Information Table 147. Dojindo Laboratories Business Overview Table 148. Dojindo Laboratories HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 149. Dojindo Laboratories HEPES Product Portfolio Table 150. Dojindo Laboratories Recent Development Table 151. XZL Bio-Technology Company Information Table 152. XZL Bio-Technology Business Overview Table 153. XZL Bio-Technology HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 154. XZL Bio-Technology HEPES Product Portfolio Table 155. XZL Bio-Technology Recent Development Table 156. Suzhou Yacoo Science Company Information Table 157. Suzhou Yacoo Science Business Overview Table 158. Suzhou Yacoo Science HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 159. Suzhou Yacoo Science HEPES Product Portfolio Table 160. Suzhou Yacoo Science Recent Development Table 161. Haihang Chemical Company Information Table 162. Haihang Chemical Business Overview Table 163. Haihang Chemical HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 164. Haihang Chemical HEPES Product Portfolio Table 165. Haihang Chemical Recent Development Table 166. Yunbang Bio-pharmaceutical Company Information Table 167. Yunbang Bio-pharmaceutical Business Overview Table 168. Yunbang Bio-pharmaceutical HEPES Sales (MT), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 169. Yunbang Bio-pharmaceutical HEPES Product Portfolio Table 170. Yunbang Bio-pharmaceutical Recent Development Table 171. North America HEPES Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 172. North America HEPES Sales by Country (2021-2026) & (MT) Table 173. North America HEPES Sales Market Share by Country (2021-2026) Table 174. North America HEPES Sales Forecast by Country (2027-2032) & (MT) Table 175. North America HEPES Sales Market Share Forecast by Country (2027-2032) Table 176. North America HEPES Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. North America HEPES Market Size by Country (2021-2026) & (US$ Million) Table 178. North America HEPES Market Share by Country (2021-2026) Table 179. North America HEPES Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. North America HEPES Market Share Forecast by Country (2027-2032) Table 181. Europe HEPES Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 182. Europe HEPES Sales by Country (2021-2026) & (MT) Table 183. Europe HEPES Sales Market Share by Country (2021-2026) Table 184. Europe HEPES Sales Forecast by Country (2027-2032) & (MT) Table 185. Europe HEPES Sales Market Share Forecast by Country (2027-2032) Table 186. Europe HEPES Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Europe HEPES Market Size by Country (2021-2026) & (US$ Million) Table 188. Europe HEPES Market Share by Country (2021-2026) Table 189. Europe HEPES Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Europe HEPES Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific HEPES Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific HEPES Sales by Country (2021-2026) & (MT) Table 193. Asia-Pacific HEPES Sales Market Share by Country (2021-2026) Table 194. Asia-Pacific HEPES Sales Forecast by Country (2027-2032) & (MT) Table 195. Asia-Pacific HEPES Sales Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific HEPES Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific HEPES Market Size by Country (2021-2026) & (US$ Million) Table 198. Asia-Pacific HEPES Market Share by Country (2021-2026) Table 199. Asia-Pacific HEPES Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Asia-Pacific HEPES Market Share Forecast by Country (2027-2032) Table 201. Latin America HEPES Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 202. Latin America HEPES Sales by Country (2021-2026) & (MT) Table 203. Latin America HEPES Sales Market Share by Country (2021-2026) Table 204. Latin America HEPES Sales Forecast by Country (2027-2032) & (MT) Table 205. Latin America HEPES Sales Market Share Forecast by Country (2027-2032) Table 206. Latin America HEPES Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Latin America HEPES Market Size by Country (2021-2026) & (US$ Million) Table 208. Latin America HEPES Market Share by Country (2021-2026) Table 209. Latin America HEPES Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Latin America HEPES Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa HEPES Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa HEPES Sales by Country (2021-2026) & (MT) Table 213. Middle East and Africa HEPES Sales Market Share by Country (2021-2026) Table 214. Middle East and Africa HEPES Sales Forecast by Country (2027-2032) & (MT) Table 215. Middle East and Africa HEPES Sales Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa HEPES Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa HEPES Market Size by Country (2021-2026) & (US$ Million) Table 218. Middle East and Africa HEPES Market Share by Country (2021-2026) Table 219. Middle East and Africa HEPES Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Middle East and Africa HEPES Market Share Forecast by Country (2027-2032) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. HEPES Distributors List Table 224. HEPES Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. HEPES Image Figure 2. Global HEPES Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HEPES Market Size (2021-2032) & (US$ Million) Figure 4. Global HEPES Sales (2021-2032) & (MT) Figure 5. HEPES Powder Image Figure 6. Global HEPES Powder Sales YoY Growth (2021-2032) & (MT) Figure 7. HEPES Solution Image Figure 8. Global HEPES Solution Sales YoY Growth (2021-2032) & (MT) Figure 9. Global HEPES Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global HEPES Market Share by Type 2025 VS 2032 Figure 11. North America HEPES Sales Market Share in Volume by Type in 2025 Figure 12. North America HEPES Sales Market Share in Value by Type in 2025 Figure 13. Europe HEPES Sales Market Share in Volume by Type in 2025 Figure 14. Europe HEPES Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific HEPES Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific HEPES Sales Market Share in Value by Type in 2025 Figure 17. Latin America HEPES Sales Market Share in Volume by Type in 2025 Figure 18. Latin America HEPES Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa HEPES Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa HEPES Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 HEPES Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cell Culture Image Figure 24. Global Cell Culture Sales YoY Growth (2021-2032) & (MT) Figure 25. Protein Extraction Image Figure 26. Global Protein Extraction Sales YoY Growth (2021-2032) & (MT) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (MT) Figure 29. Global HEPES Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global HEPES Market Share by Application 2025 VS 2032 Figure 31. North America HEPES Sales Market Share in Volume by Application in 2025 Figure 32. North America HEPES Sales Market Share in Value by Application in 2025 Figure 33. Europe HEPES Sales Market Share in Volume by Application in 2025 Figure 34. Europe HEPES Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific HEPES Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific HEPES Sales Market Share in Value by Application in 2025 Figure 37. Latin America HEPES Sales Market Share in Volume by Application in 2025 Figure 38. Latin America HEPES Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa HEPES Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa HEPES Sales Market Share in Value by Application in 2025 Figure 41. North America HEPES Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 42. North America HEPES Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America HEPES Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America HEPES Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe HEPES Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 46. Europe HEPES Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe HEPES Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe HEPES Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific HEPES Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 50. Asia-Pacific HEPES Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific HEPES Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific HEPES Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America HEPES Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 54. Latin America HEPES Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America HEPES Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America HEPES Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa HEPES Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 58. Middle East and Africa HEPES Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa HEPES Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa HEPES Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. HEPES Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. HEPES Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • HEPES Powder
  • HEPES Solution
Applications
  • Cell Culture
  • Protein Extraction
  • Others
Companies covered
  • Avantor
  • Thermo Fisher
  • Merck
  • Lonza
  • Cytiva
  • Promega Corporation
  • MP Biomedicals
  • Spectrum Laboratory
  • Biological Industries
  • Cayman Chemical
  • SERVA Electrophoresis GmbH
  • Bio-Techne
  • BioSpectra
  • Corning
  • FUJIFILM Irvine Scientific, Inc.
  • Dojindo Laboratories
  • XZL Bio-Technology
  • Suzhou Yacoo Science
  • Haihang Chemical
  • Yunbang Bio-pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global HEPES Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global HEPES Sales Estimates and Forecasts (2021-2032)
  5. 1.3 HEPES Market by Type
  6. 1.3.1 HEPES Powder
  7. 1.3.2 HEPES Solution
  8. 1.4 Global HEPES Market Size by Type
  9. 1.4.1 Global HEPES Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global HEPES Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global HEPES Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America HEPES Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe HEPES Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific HEPES Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America HEPES Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa HEPES Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 HEPES Industry Trends
  2. 2.2 HEPES Industry Drivers
  3. 2.3 HEPES Industry Opportunities and Challenges
  4. 2.4 HEPES Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by HEPES Revenue (2021-2026)
  2. 3.2 Global Top Players by HEPES Sales (2021-2026)
  3. 3.3 Global Top Players by HEPES Price (2021-2026)
  4. 3.4 Global HEPES Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global HEPES Major Company Production Sites & Headquarters
  6. 3.6 Global HEPES Company, Product Type & Application
  7. 3.7 Global HEPES Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global HEPES Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 HEPES Players Market Share by Revenue in 2025
  11. 3.8.3 2025 HEPES Tier 1, Tier 2, and Tier 3
4 HEPES Regional Status and Outlook
  1. 4.1 Global HEPES Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global HEPES Historic Market Size by Region
  3. 4.2.1 Global HEPES Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global HEPES Sales in Value by Region (2021-2026)
  5. 4.2.3 Global HEPES Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global HEPES Forecasted Market Size by Region
  7. 4.3.1 Global HEPES Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global HEPES Sales in Value by Region (2027-2032)
  9. 4.3.3 Global HEPES Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 HEPES by Application
  1. 5.1 HEPES Market by Application
  2. 5.1.1 Cell Culture
  3. 5.1.2 Protein Extraction
  4. 5.1.3 Others
  5. 5.2 Global HEPES Market Size by Application
  6. 5.2.1 Global HEPES Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global HEPES Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global HEPES Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America HEPES Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe HEPES Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific HEPES Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America HEPES Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa HEPES Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Avantor
  2. 6.1.1 Avantor Company Information
  3. 6.1.2 Avantor Business Overview
  4. 6.1.3 Avantor HEPES Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Avantor HEPES Product Portfolio
  6. 6.1.5 Avantor Recent Developments
  7. 6.2 Thermo Fisher
  8. 6.2.1 Thermo Fisher Company Information
  9. 6.2.2 Thermo Fisher Business Overview
  10. 6.2.3 Thermo Fisher HEPES Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Thermo Fisher HEPES Product Portfolio
  12. 6.2.5 Thermo Fisher Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck HEPES Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck HEPES Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Lonza
  20. 6.4.1 Lonza Company Information
  21. 6.4.2 Lonza Business Overview
  22. 6.4.3 Lonza HEPES Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Lonza HEPES Product Portfolio
  24. 6.4.5 Lonza Recent Developments
  25. 6.5 Cytiva
  26. 6.5.1 Cytiva Company Information
  27. 6.5.2 Cytiva Business Overview
  28. 6.5.3 Cytiva HEPES Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Cytiva HEPES Product Portfolio
  30. 6.5.5 Cytiva Recent Developments
  31. 6.6 Promega Corporation
  32. 6.6.1 Promega Corporation Company Information
  33. 6.6.2 Promega Corporation Business Overview
  34. 6.6.3 Promega Corporation HEPES Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Promega Corporation HEPES Product Portfolio
  36. 6.6.5 Promega Corporation Recent Developments
  37. 6.7 MP Biomedicals
  38. 6.7.1 MP Biomedicals Company Information
  39. 6.7.2 MP Biomedicals Business Overview
  40. 6.7.3 MP Biomedicals HEPES Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 MP Biomedicals HEPES Product Portfolio
  42. 6.7.5 MP Biomedicals Recent Developments
  43. 6.8 Spectrum Laboratory
  44. 6.8.1 Spectrum Laboratory Company Information
  45. 6.8.2 Spectrum Laboratory Business Overview
  46. 6.8.3 Spectrum Laboratory HEPES Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Spectrum Laboratory HEPES Product Portfolio
  48. 6.8.5 Spectrum Laboratory Recent Developments
  49. 6.9 Biological Industries
  50. 6.9.1 Biological Industries Company Information
  51. 6.9.2 Biological Industries Business Overview
  52. 6.9.3 Biological Industries HEPES Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Biological Industries HEPES Product Portfolio
  54. 6.9.5 Biological Industries Recent Developments
  55. 6.10 Cayman Chemical
  56. 6.10.1 Cayman Chemical Company Information
  57. 6.10.2 Cayman Chemical Business Overview
  58. 6.10.3 Cayman Chemical HEPES Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Cayman Chemical HEPES Product Portfolio
  60. 6.10.5 Cayman Chemical Recent Developments
  61. 6.11 SERVA Electrophoresis GmbH
  62. 6.11.1 SERVA Electrophoresis GmbH Company Information
  63. 6.11.2 SERVA Electrophoresis GmbH Business Overview
  64. 6.11.3 SERVA Electrophoresis GmbH HEPES Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 SERVA Electrophoresis GmbH HEPES Product Portfolio
  66. 6.11.5 SERVA Electrophoresis GmbH Recent Developments
  67. 6.12 Bio-Techne
  68. 6.12.1 Bio-Techne Company Information
  69. 6.12.2 Bio-Techne Business Overview
  70. 6.12.3 Bio-Techne HEPES Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Bio-Techne HEPES Product Portfolio
  72. 6.12.5 Bio-Techne Recent Developments
  73. 6.13 BioSpectra
  74. 6.13.1 BioSpectra Company Information
  75. 6.13.2 BioSpectra Business Overview
  76. 6.13.3 BioSpectra HEPES Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 BioSpectra HEPES Product Portfolio
  78. 6.13.5 BioSpectra Recent Developments
  79. 6.14 Corning
  80. 6.14.1 Corning Company Information
  81. 6.14.2 Corning Business Overview
  82. 6.14.3 Corning HEPES Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Corning HEPES Product Portfolio
  84. 6.14.5 Corning Recent Developments
  85. 6.15 FUJIFILM Irvine Scientific, Inc.
  86. 6.15.1 FUJIFILM Irvine Scientific, Inc. Company Information
  87. 6.15.2 FUJIFILM Irvine Scientific, Inc. Business Overview
  88. 6.15.3 FUJIFILM Irvine Scientific, Inc. HEPES Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 FUJIFILM Irvine Scientific, Inc. HEPES Product Portfolio
  90. 6.15.5 FUJIFILM Irvine Scientific, Inc. Recent Developments
  91. 6.16 Dojindo Laboratories
  92. 6.16.1 Dojindo Laboratories Company Information
  93. 6.16.2 Dojindo Laboratories Business Overview
  94. 6.16.3 Dojindo Laboratories HEPES Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Dojindo Laboratories HEPES Product Portfolio
  96. 6.16.5 Dojindo Laboratories Recent Developments
  97. 6.17 XZL Bio-Technology
  98. 6.17.1 XZL Bio-Technology Company Information
  99. 6.17.2 XZL Bio-Technology Business Overview
  100. 6.17.3 XZL Bio-Technology HEPES Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 XZL Bio-Technology HEPES Product Portfolio
  102. 6.17.5 XZL Bio-Technology Recent Developments
  103. 6.18 Suzhou Yacoo Science
  104. 6.18.1 Suzhou Yacoo Science Company Information
  105. 6.18.2 Suzhou Yacoo Science Business Overview
  106. 6.18.3 Suzhou Yacoo Science HEPES Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Suzhou Yacoo Science HEPES Product Portfolio
  108. 6.18.5 Suzhou Yacoo Science Recent Developments
  109. 6.19 Haihang Chemical
  110. 6.19.1 Haihang Chemical Company Information
  111. 6.19.2 Haihang Chemical Business Overview
  112. 6.19.3 Haihang Chemical HEPES Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Haihang Chemical HEPES Product Portfolio
  114. 6.19.5 Haihang Chemical Recent Developments
  115. 6.20 Yunbang Bio-pharmaceutical
  116. 6.20.1 Yunbang Bio-pharmaceutical Company Information
  117. 6.20.2 Yunbang Bio-pharmaceutical Business Overview
  118. 6.20.3 Yunbang Bio-pharmaceutical HEPES Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Yunbang Bio-pharmaceutical HEPES Product Portfolio
  120. 6.20.5 Yunbang Bio-pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America HEPES Sales by Country
  2. 7.1.1 North America HEPES Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America HEPES Sales by Country (2021-2026)
  4. 7.1.3 North America HEPES Sales Forecast by Country (2027-2032)
  5. 7.2 North America HEPES Market Size by Country
  6. 7.2.1 North America HEPES Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America HEPES Market Size by Country (2021-2026)
  8. 7.2.3 North America HEPES Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe HEPES Sales by Country
  2. 8.1.1 Europe HEPES Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe HEPES Sales by Country (2021-2026)
  4. 8.1.3 Europe HEPES Sales Forecast by Country (2027-2032)
  5. 8.2 Europe HEPES Market Size by Country
  6. 8.2.1 Europe HEPES Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe HEPES Market Size by Country (2021-2026)
  8. 8.2.3 Europe HEPES Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific HEPES Sales by Country
  2. 9.1.1 Asia-Pacific HEPES Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific HEPES Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific HEPES Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific HEPES Market Size by Country
  6. 9.2.1 Asia-Pacific HEPES Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific HEPES Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific HEPES Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America HEPES Sales by Country
  2. 10.1.1 South America HEPES Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America HEPES Sales by Country (2021-2026)
  4. 10.1.3 South America HEPES Sales Forecast by Country (2027-2032)
  5. 10.2 South America HEPES Market Size by Country
  6. 10.2.1 South America HEPES Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America HEPES Market Size by Country (2021-2026)
  8. 10.2.3 South America HEPES Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa HEPES Sales by Country
  2. 11.1.1 Middle East and Africa HEPES Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa HEPES Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa HEPES Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa HEPES Market Size by Country
  6. 11.2.1 Middle East and Africa HEPES Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa HEPES Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa HEPES Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 HEPES Value Chain Analysis
  2. 12.1.1 HEPES Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 HEPES Production Mode & Process
  7. 12.2 HEPES Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 HEPES Distributors
  10. 12.2.3 HEPES Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research